Last reviewed · How we verify

Crisaborole Vehicle — Competitive Intelligence Brief

Crisaborole Vehicle (Crisaborole Vehicle) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Phosphodiesterase 4 (PDE4) inhibitor. Area: Dermatology.

marketed Phosphodiesterase 4 (PDE4) inhibitor PDE4 Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Crisaborole Vehicle (Crisaborole Vehicle) — Pfizer. Crisaborole is a phosphodiesterase 4 (PDE4) inhibitor that reduces inflammatory cytokine production in atopic dermatitis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Crisaborole Vehicle TARGET Crisaborole Vehicle Pfizer marketed Phosphodiesterase 4 (PDE4) inhibitor PDE4
Otezla APREMILAST Amgen marketed Phosphodiesterase 4 Inhibitor [EPC] PDE4 2014-01-01
Crisaborole ointment, 2% Crisaborole ointment, 2% Pfizer marketed Phosphodiesterase 4 (PDE4) inhibitor PDE4
Apremilast (CC-10004) Apremilast (CC-10004) Virginia Clinical Research, Inc. marketed Phosphodiesterase 4 (PDE4) inhibitor PDE4
crisaborole ointment crisaborole ointment Pfizer phase 3 PDE4 inhibitor PDE4
MP513 MP513 Handok Inc. phase 3 PDE4 inhibitor PDE4
RPH-051 RPH-051 R-Pharm phase 3 PDE4 inhibitor PDE4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Phosphodiesterase 4 (PDE4) inhibitor class)

  1. Pfizer · 6 drugs in this class
  2. Shire · 3 drugs in this class
  3. Almirall, S.A. · 3 drugs in this class
  4. Arcutis Biotherapeutics, Inc. · 2 drugs in this class
  5. LEO Pharma · 2 drugs in this class
  6. ORA, Inc. · 1 drug in this class
  7. Tillotts Pharma AG · 1 drug in this class
  8. AbbVie (prior sponsor, Abbott) · 1 drug in this class
  9. Virginia Clinical Research, Inc. · 1 drug in this class
  10. Alfasigma S.p.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Crisaborole Vehicle — Competitive Intelligence Brief. https://druglandscape.com/ci/crisaborole-vehicle. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: